Charles Stark
Chief Tech/Sci/R&D Officer at EMMAUS LIFE SCIENCES, INC.
Net worth: 1 855 $ as of 2024-04-29
Charles Stark active positions
Companies | Position | Start | End |
---|---|---|---|
EMMAUS LIFE SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2019-07-18 | - |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Chief Tech/Sci/R&D Officer | 2013-10-31 | - |
St. Mary's Regional Medical Center (Oklahoma)
St. Mary's Regional Medical Center (Oklahoma) Hospital/Nursing ManagementHealth Services St. Mary's Regional Medical Center provides healthcare services. It offers emergency and telehealth services and insurance. The company is headquartered in Enid, OK. | Director/Board Member | - | - |
Career history of Charles Stark
Former positions of Charles Stark
Companies | Position | Start | End |
---|---|---|---|
Health Research Association, Inc. | Corporate Officer/Principal | - | - |
Los Angeles County+USC Medical Center | Corporate Officer/Principal | - | - |
Harbor-UCLA Medical Center
Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Harbor-UCLA Medical Center provides medical practice, education, and research services. The private company is based in Torrance, CA. | Corporate Officer/Principal | - | - |
Los Angeles Biomedical Research Institute at Harbor-UCLA
Los Angeles Biomedical Research Institute at Harbor-UCLA BiotechnologyHealth Technology Los Angeles Biomedical Research Institute at Harbor-UCLA, also known as the Lundquist Institute, is a non-profit research organization located in Torrance, CA. The institute has also started working on a vaccine for the urgent fungal threat, Candida auris, which is spreading at an alarming rate throughout healthcare facilities in the US and is resistant to several antifungal drugs. The institute focuses on biomedical research, clinical trials, and community outreach programs. The institute has various research theme groups and researchers working on different projects, including the Institute for Translational Genomics and Population Sciences, which contributes to new research in genomics. The Lundquist Institute has received several grants and gifts for its research, including a $1.50 million gift from Farima and Joseph Czyzyk for the Diagnostic and Wellness Center. The CEO of the private company is David I. Meyer. | Corporate Officer/Principal | - | - |
PFIZER, INC. | Corporate Officer/Principal | - | - |
DENDREON CORPORATION | Corporate Officer/Principal | - | - |
░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Charles Stark
University of Southern California | Doctorate Degree |
Statistics
International
United States | 11 |
Denmark | 2 |
Operational
Corporate Officer/Principal | 7 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 7 |
Health Services | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
PFIZER, INC. | Health Technology |
BAVARIAN NORDIC A/S | Health Technology |
EMMAUS LIFE SCIENCES, INC. | Health Technology |
Private companies | 7 |
---|---|
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Health Technology |
Los Angeles Biomedical Research Institute at Harbor-UCLA
Los Angeles Biomedical Research Institute at Harbor-UCLA BiotechnologyHealth Technology Los Angeles Biomedical Research Institute at Harbor-UCLA, also known as the Lundquist Institute, is a non-profit research organization located in Torrance, CA. The institute has also started working on a vaccine for the urgent fungal threat, Candida auris, which is spreading at an alarming rate throughout healthcare facilities in the US and is resistant to several antifungal drugs. The institute focuses on biomedical research, clinical trials, and community outreach programs. The institute has various research theme groups and researchers working on different projects, including the Institute for Translational Genomics and Population Sciences, which contributes to new research in genomics. The Lundquist Institute has received several grants and gifts for its research, including a $1.50 million gift from Farima and Joseph Czyzyk for the Diagnostic and Wellness Center. The CEO of the private company is David I. Meyer. | Health Technology |
Health Research Association, Inc. | |
St. Mary's Regional Medical Center (Oklahoma)
St. Mary's Regional Medical Center (Oklahoma) Hospital/Nursing ManagementHealth Services St. Mary's Regional Medical Center provides healthcare services. It offers emergency and telehealth services and insurance. The company is headquartered in Enid, OK. | Health Services |
Los Angeles County+USC Medical Center | |
Harbor-UCLA Medical Center
Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Harbor-UCLA Medical Center provides medical practice, education, and research services. The private company is based in Torrance, CA. | Health Services |
- Stock Market
- Insiders
- Charles Stark
- Experience